McKesson Corporation (LON:0JZU)
London · Delayed Price · Currency is GBP · Price in USD 825.99
+15.59 (1.92%)
At close: Dec 19, 2025
McKesson Market Cap
McKesson has a market cap or net worth of 75.7 billion as of December 19, 2025. Its market cap has increased by 23.90% in one year.
Market Cap
75.70B
Enterprise Value
81.02B
Revenue
287.97B
Ranking
n/a
PE Ratio
25.23
Stock Price
825.99
Market Cap Chart
Since November 10, 1994, McKesson's market cap has increased from 904.45M to 75.70B, an increase of 8,269.62%. That is a compound annual growth rate of 15.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 75.70B | 31.00% |
| Dec 31, 2024 | 57.79B | 19.48% |
| Dec 29, 2023 | 48.37B | 9.56% |
| Dec 30, 2022 | 44.14B | 57.50% |
| Dec 31, 2021 | 28.03B | 37.03% |
| Dec 31, 2020 | 20.45B | 8.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.02B |
| GSK plc | 72.73B |
| Haleon | 33.29B |
| Smith & Nephew | 10.48B |
| Convatec Group | 4.72B |
| Hikma Pharmaceuticals | 3.34B |
| HUTCHMED (China) | 1.71B |
| Genus | 1.71B |